Esaote unveils its integrated imaging and ultrasound innovations at ECR

Manufacturer of medical imaging technology Esaote Group presented its new portfolio of imaging solutions at the European Congress of Radiology (ECR) in Vienna, Austria.

Esaote’s AI technology is now integrated into a variety of clinical applications. In the field of MRI, Esaote launched an AI platform called e-SPADES. This technology, developed in collaboration with the Amsterdam University Medical Center and AIRS Medical, can reduce overall examination time by up to 60 per cent compared to conventional scanning, while delivering exceptional image quality.

In ultrasound, Esaote’s Augmented Insight AI technology now powers the entire system portfolio, from the flagship MyLab X90 to the MyLab C30, which was also unveiled at ECR. Together with the MyLab C25, Esaote’s new ultrasound C-series combines portability with performance and Italian design, with a cleanable touch keyboard and gesture-enabled trackpad.

ECR also provided an opportunity for EBIT, the Esaote Group company specialising in healthcare information technology, to showcase its cloud-native PACS solution Suitestensa ZefiRO. Offering zero-footprint technology, Suitestensa ZefiRO allows physicians and operators to view medical images easily and efficiently from any location. It features Suitestensa fAInd, an AI platform that provides quick access to numerous clinical applications to facilitate reporting and workflow.

“Our ongoing R&D efforts are focused on improving diagnostic accuracy and image-guided interventions by leveraging powerful technologies that increasingly rely on AI and advanced software applications as their backbone,” said Esaote CEO Franco Fontana. “Our new MRI and ultrasound portfolio is supported by integrated IT platforms that enable healthcare professionals to focus on delivering precision patient care.”

Picture: Esaote CEO Franco Fontana.

Read this report on page 10 of the April 2025 issue of RAD Magazine.